Radionuclide Decay, Emissions & Therapeutic Radiopharmaceutical QC | Postgraduate Nuclear Medicine
Dr Anil Kumar Pandey , AIIMS, New Delhi
0:00 / 0:00
Radionuclide Decay, Emissions & Therapeutic Radiopharmaceutical QC | Postgraduate Nuclear Medicine
25 просмотров · 6 дней назад
Dr Anil Kumar Pandey , AIIMS, New Delhi
26 подписчиков
25 просмотров · 6 дней назад
Radionuclide Decay, Emissions & Therapeutic Radiopharmaceutical QC | Postgraduate Nuclear Medicine
This lecture provides a comprehensive, concept-based discussion of radionuclide decay, radiation emissions, therapeutic radionuclides, theranostics, and quality control of therapeutic radiopharmaceuticals, designed specifically for postgraduate Nuclear Medicine students and residents.
Topics covered
🔹 Nuclear Stability & Decay
Nuclear stability and the N–Z relationship
Neutron-rich vs proton-rich radionuclides
β⁻ decay and isobaric transmutation
β⁺ decay and electron capture
Q-value and energy conservation
🔹 Beta Radiation Physics
Continuous β⁻ and β⁺ energy spectra
Endpoint energy and mean beta energy
Antineutrino and neutrino energy sharing
Positron range and energy loss
🔹 Bremsstrahlung & Radiation Shielding
Production of bremsstrahlung X-rays
Effect of electron energy and absorber atomic number
Low-Z followed by high-Z shielding principle
Practical radiation-safety implications for high-energy β emitters
🔹 Gamma Emission & Isomeric Transition
Nuclear energy levels
Discrete gamma-ray energies
Metastable states
Isomeric transition
Technetium-99m as a clinical example
🔹 Internal Conversion
Internal conversion mechanism
Conversion-electron energy
K-, L- and M-shell conversion
Internal conversion coefficient
Characteristic X-rays and Auger electrons
🔹 Diagnostic Radionuclides
Comparison of:
⁹⁹ᵐTc
¹³¹I
¹⁸F
⁶⁷Ga
¹¹¹In
with emphasis on their decay modes, photon emissions and clinical Nuclear Medicine applications.
🔹 Therapeutic Radionuclides
³²P
⁸⁹Sr
⁹⁰Y
¹⁵³Sm
¹⁷⁷Lu
²²³Ra
The lecture discusses:
β⁻ and α particle therapy
Tissue range
LET
Crossfire effect
High-LET alpha radiation
Short-range versus millimetre-range radiation
Theranostic applications
🔹 Theranostics
¹⁷⁷Lu-based therapy
Therapeutic β⁻ emission
Accompanying γ emissions
Post-therapy SPECT
Image-guided therapy and internal dosimetry concepts
⁹⁰Y bremsstrahlung imaging
🔹 Therapeutic Radiopharmaceutical Quality Control
A systematic QC framework covering:
Radionuclidic purity
Parent breakthrough
Radiochemical purity (RCP)
ITLC and HPLC
Chemical purity
Trace-metal contamination
Radioassay and dose calibrator
Particle-size analysis
Sterility
Bacterial endotoxin testing
Biological safety
Postgraduate-level clinical reasoning
The lecture also includes case-based questions and troubleshooting concepts, encouraging students to move beyond memorization and answer questions such as:
• Why should high-energy β emitters not be shielded with lead alone?
• Why is the β spectrum continuous?
• Why does positron range affect PET resolution?
• How does internal conversion differ from gamma emission?
• Why does ⁹⁰Y produce a crossfire effect?
• Why is alpha therapy highly localized?
• What happens when radiochemical purity is low?
• Why can a small amount of parent breakthrough be clinically important?
• How can trace-metal contamination affect radiolabeling?
• How should a therapeutic radiopharmaceutical QC failure be interpreted?
Python Simulation Component
The lecture is supported by a set of 15 Python-based educational simulations covering nuclear stability, beta spectra, bremsstrahlung, positron physics, PET annihilation, gamma energy levels, internal conversion, therapeutic radionuclides, LET, crossfire, ¹⁷⁷Lu theranostics and radiopharmaceutical QC.
These simulations can be used for classroom demonstrations, postgraduate teaching, assignments and self-learning.
Who should watch?
This lecture is particularly useful for:
MD/DNB Nuclear Medicine residents
Postgraduate Nuclear Medicine students
Nuclear Medicine physicians
Medical physicists
Radiopharmacists
Nuclear Medicine technologists
Students preparing for Nuclear Medicine examinations
Professionals interested in radionuclide therapy and theranostics
Important note
The numerical simulations discussed in this lecture are educational models intended to demonstrate physical principles. They should not be used as substitutes for validated clinical dosimetry software, radionuclide transport codes, pharmacopoeial QC procedures, product-specific specifications or regulatory requirements.
If you find the lecture useful, Like, Share and Subscribe for more postgraduate-level Nuclear Medicine lectures, physics simulations, radiopharmaceutical science and theranostics content.